Mc-Val-Cit-PABC-PNP: Technical Guidance for ADC Linker Use

What This Product Solves

Mc-Val-Cit-PABC-PNP addresses a key challenge in antibody-drug conjugate (ADC) synthesis: the need for a reliable, cathepsin B-cleavable peptide linker that enables selective release of cytotoxic agents within lysosomes of target cells. By incorporating a substrate sequence (Val-Cit) recognized by lysosomal cathepsin proteases and a self-immolative PABC (para-aminobenzyloxycarbonyl) spacer, this linker facilitates efficient drug release upon internalization. The product's high solubility in DMSO and compatibility with organic-phase conjugation workflows make it a practical choice for research on targeted drug delivery, particularly where aqueous solubility is not essential. Researchers seeking to design ADCs with controlled, intracellular payload activation benefit from the use of this linker in preclinical protocol development.

For further details on the practical application of this linker in ADC workflows, the article Mc-Val-Cit-PABC-PNP: Technical Guide for ADC Peptide Linker Use provides additional guidance on lysosomal cleavage specificity. Additionally, Protocol Guidance for ADC Linker Use covers workflow considerations when using organic solvents.

Protocol Parameters

• Solubility (DMSO): ≥36.9 mg/mL | Suitable for organic-phase ADC synthesis | Ensures adequate concentration for conjugation reactions | product information
• Recommended Storage Temperature: -20°C (solid) | Long-term solid storage | Preserves compound integrity; prevents degradation | product information
• Solution Stability: Use promptly after preparation | For immediate conjugation workflows | Solutions degrade over time; avoid extended storage in solution | product information
• Purity: 98.00% (as supplied) | Suitable for research ADC synthesis | Minimizes risk of side reactions during conjugation | product information
• Chemical Formula / MW: C35H43N7O11, 737.76 g/mol | Use for stoichiometric calculations | Accurate dosing in conjugation reactions | product information
• Solubility in Water/Ethanol: Insoluble | Not suitable for aqueous-phase protocols | Prevents precipitation or incomplete dissolution in water-based workflows | product information

Workflow Setup and QC Checklist

• Preparation: Weigh Mc-Val-Cit-PABC-PNP in a dry, inert environment to avoid moisture uptake and hydrolysis. Use powder directly from -20°C storage, minimizing exposure to ambient conditions.
• Dissolution: Dissolve the linker in anhydrous DMSO at the recommended concentration (e.g., 10–30 mg/mL, not exceeding the solubility limit). Ensure complete dissolution by gentle vortexing or sonication. Avoid using water or ethanol as solvents.
• ADC Conjugation: Add the DMSO solution of the linker to the antibody and payload components under controlled, anhydrous conditions. Maintain reaction temperatures as required by your protocol, typically at 4°C to room temperature for coupling steps. Monitor conjugation progress using HPLC or SDS-PAGE as applicable to verify linker attachment.
• Purification: Following conjugation, purify the ADC construct by size-exclusion chromatography or ultrafiltration to remove excess linker and DMSO. Characterize the final conjugate for drug-to-antibody ratio (DAR) and confirm absence of free linker.
• Quality Control: Validate cleavage response by exposing a small aliquot of the ADC to cathepsin B or lysosomal extract and analyzing payload release (LC-MS or HPLC recommended). Confirm that the linker is effectively cleaved under lysosomal-mimetic conditions.
• Solution Handling: Prepare only the volume of linker solution needed for immediate use. Discard unused solutions after the experiment to avoid degradation or hydrolysis.

Common Failure Modes and Fixes

• Incomplete Dissolution: If the linker fails to dissolve in DMSO, verify solvent dryness and temperature. Warm gently (not exceeding 37°C) while vortexing. Do not attempt to dissolve in aqueous buffers.
• Precipitation During Conjugation: If precipitation occurs after mixing with other components, confirm all reagents are in compatible organic solvents. Gradually add the linker solution to avoid local concentration spikes.
• Low Conjugation Efficiency: Check for moisture contamination or expired linker/reagent stocks. Validate antibody accessibility and adjust linker-to-protein molar ratios as needed based on preliminary optimization.
• Instability of Linker Solution: If degradation is observed (e.g., by LC-MS), ensure solutions are freshly prepared and protected from light and moisture. Use prepared solution immediately.
• Insufficient Lysosomal Cleavage: If the payload is not efficiently released, verify cathepsin B activity in the cleavage assay and confirm linker integrity prior to conjugation. Consider repeating the QC cleavage step with positive controls.

Scope and Limitations

Mc-Val-Cit-PABC-PNP is optimized for research use in organic-phase ADC workflows, specifically those requiring cathepsin B substrate linkers for lysosomal cleavage. It is not suitable for diagnostic, therapeutic, or in vivo protocols involving aqueous or biological fluids, due to insolubility outside organic solvents and product restrictions. The linker is intended for scientific research use only, as detailed on the APExBIO product page. Long-term storage of solutions is not recommended; only freshly prepared solutions should be used. The product should not be used in water-based conjugation or where aqueous solubility of the linker is necessary. Adherence to chemical safety and waste disposal protocols is required.

Conclusion

Mc-Val-Cit-PABC-PNP offers a reliable and well-characterized option for ADC linker design in targeted drug delivery research, enabling controlled intracellular release via lysosomal cathepsin B cleavage. Its use is best confined to organic-solvent-based workflows, with careful attention to solution handling and storage stability. For detailed technical parameters, researchers should refer to the product listing at APExBIO, ensuring protocol alignment with the compound's solubility, stability, and application boundaries.